Pharmatek, a contract development and manufacturing organization, has invested to expand its spray-drying capabilities. The company has purchased a second GEA Niro Mobile Minor, in addition to a ProCepT 4M8-Trix, and a GEA Niro SD Micro for the development and GMP manufacture of amorphous spray dried dispersions.

The purchases complement existing spray-drying equipment, including a GEA Niro Mobile Minor and a Buchi B-290.

Pharmatek offers formulation development, process scale-up and GMP manufacturing services for small molecules and peptides. Spray drying is part of the company’s amorphous dispersion drug development capabilities that include physical characterization, preformulation testing, analytical development, formulation development and GMP manufacturing of finished dosage forms.

Source: Pharmatek